Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page is updated to reflect a new ClinicalTrials.gov interface/release revision number (from v3.5.2 to v3.5.3). This represents a site maintenance/version change rather than a change to the underlying study information.SummaryDifference0.1%

- Check28 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no visible changes to the study details or page layout.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision history updated for study documents: added revision v3.4.2 and removed v3.4.1.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded document revision tag v3.4.1 and removed v3.4.0; these are metadata updates that do not affect the study details, eligibility criteria, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.